Three publications from the past week:

• A three-year follow-up study evaluating clinical utility of exome sequencing and diagnostic potential of reanalysis | link
• Clinical Utilization, Utility, and Reimbursement for Expanded Genomic Panel Testing in Adult Oncology | link
• Cost-effectiveness analysis comparing companion diagnostic tests for EGFR, ALK, and ROS1 versus next-generation sequencing (NGS) in advanced adenocarcinoma lung cancer patients | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics!